Cover Image
Read Now

Injectable opioid agonist treatment for patients with opioid dependence : a review of clinical and cost-effectiveness

The purpose of this review is to summarize the evidence on the clinical effectiveness and cost-effectiveness of injectable opioid agonist treatment (with DAM or HDM, alone or in combination with methadone or buprenorphine/naloxone), compared with alternative pharmacological treatments or no treatmen...

Full description

Bibliographic Details
Main Authors: Banerjee, Srabani, Wright, Mary-Doug (Author)
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa CADTH 2020, May 27, 2020
Edition:Version: 1.0
Series:CADTH rapid response report : summary with critical appraisal
Subjects:
Analgesics, Opioid / Therapeutic Use
Cost-benefit Analysis
Opiate Substitution Treatment / Methods
Analgesics, Opioid / Administration & Dosage
Opioid-related Disorders / Drug Therapy
Treatment Outcome
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Description
Summary:The purpose of this review is to summarize the evidence on the clinical effectiveness and cost-effectiveness of injectable opioid agonist treatment (with DAM or HDM, alone or in combination with methadone or buprenorphine/naloxone), compared with alternative pharmacological treatments or no treatment, for individuals with opioid dependency
Physical Description:1 PDF file (28 pages) illustration

Similar Items